Triple

T2190751
Position Surface form Disambiguated ID Type / Status
Subject Janssen COVID-19 Vaccine E49854 entity
Predicate usesViralVector P37227 FINISHED
Object human adenovirus serotype 26 (Ad26)
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
E241391 NE FINISHED

How this triple was built (5 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: human adenovirus serotype 26 (Ad26) | Statement: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: human adenovirus serotype 26 (Ad26)
Context triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
  • A. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • B. Immunix
    Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
  • C. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • D. The O2 complex
    The O2 complex is a large entertainment district in London featuring the O2 Arena, cinemas, restaurants, bars, and various leisure and retail facilities housed under the iconic dome structure.
  • E. Lextran
    Lextran is the public bus transit system serving Lexington and surrounding areas in Fayette County, Kentucky.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: human adenovirus serotype 26 (Ad26)
Triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
Generated description
Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: human adenovirus serotype 26 (Ad26)
Target entity description: Human adenovirus serotype 26 (Ad26) is a non-replicating viral vector commonly used in vaccine development to deliver genetic material encoding target antigens and stimulate an immune response.
  • A. rVSV-ZEBOV
    rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
  • B. Immunix
    Immunix was a security-focused software company known for developing Linux security technologies, including the precursor to the AppArmor mandatory access control system.
  • C. Leqembi
    Leqembi is an Alzheimer’s disease drug (lecanemab) that targets amyloid-beta plaques to slow cognitive decline in early-stage patients.
  • D. The O2 complex
    The O2 complex is a large entertainment district in London featuring the O2 Arena, cinemas, restaurants, bars, and various leisure and retail facilities housed under the iconic dome structure.
  • E. Lextran
    Lextran is the public bus transit system serving Lexington and surrounding areas in Fayette County, Kentucky.
  • F. None of above. chosen
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: usesViralVector
Context triple: [Janssen COVID-19 Vaccine, usesViralVector, human adenovirus serotype 26 (Ad26)]
  • A. virusSubtype
    Indicates the specific subtype classification of a virus within a broader virus type or strain.
  • B. hasVector
    Indicates that an entity is associated with, or can be represented by, a specific vector in some vector space.
  • C. vaccineUsed
    Indicates that a particular vaccine has been administered or applied in a given medical or experimental context.
  • D. hasCulturalTransmission
    Indicates that a cultural trait, practice, or knowledge is passed from one entity (such as an individual, group, or generation) to another.
  • E. isMajorCarrierOf
    Indicates that one entity serves as the primary or principal transporter or conveyor of another entity (such as goods, signals, or passengers).
  • F. None of above. chosen

Provenance (7 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a88aaba3c48190b351cab9b26989ff completed March 4, 2026, 7:40 p.m.
NER Named-entity recognition batch_69abbf9e99f08190892d34485c8f2f25 completed March 7, 2026, 6:03 a.m.
NED1 Entity disambiguation (via context triple) batch_69ae5db0352c8190aa9c4c58460df3a4 completed March 9, 2026, 5:42 a.m.
NEDg Description generation batch_69ae5e60b45c819088bf18ae564f0d1a completed March 9, 2026, 5:45 a.m.
NED2 Entity disambiguation (via description) batch_69ae5ec4a35c8190bffc7a183497e764 completed March 9, 2026, 5:46 a.m.
PD Predicate disambiguation batch_69abbda32d1881909d1fd83a751fb21c completed March 7, 2026, 5:54 a.m.
PDg Predicate description generation batch_69abbf9c77fc8190a323bcaf644fb2c5 completed March 7, 2026, 6:03 a.m.
Created at: March 4, 2026, 7:46 p.m.